Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Concetta Quintarelli

Showing results (71-80 of 89) with videos related to

Pageof 9
Sort By:
Frontiers in Immunology|June 12, 2023
Functional CVIDs phenotype clusters identified by the integration of immune parameters after BNT162b2 boostersEva Piano Mortari, Federica Pulvirenti, Valentina Marcellini, et al.
Neuro-Oncology|December 29, 2021
Dual IGF1R/IR inhibitors in combination with GD2-CAR T-cells display a potent anti-tumor activity in diffuse midline glioma H3K27M-mutantEmmanuel de Billy, Marsha Pellegrino, Domenico Orlando, et al.
Acta Neuropathologica|July 24, 2021
Targeting cancer stem cells in medulloblastoma by inhibiting AMBRA1 dual function in autophagy and STAT3 signallingFrancesca Nazio, Agnese Po, Luana Abballe, et al.
Journal for Immunotherapy of Cancer|May 16, 2022
Time 2EVOLVE: predicting efficacy of engineered T-cells - how far is the bench from the bedside?Sonia Guedan, Maik Luu, Delphine Ammar, et al.
Haematologica|May 9, 2020
CD28.OX40 co-stimulatory combination is associated with long in vivo persistence and high activity of CAR.CD30 T-cellsMarika Guercio, Domenico Orlando, Stefano Di Cecca, et al.
Journal of Immunology Research|August 28, 2020
Corrigendum to "Multicentre Harmonisation of a Six-Colour Flow Cytometry Panel for Naïve/Memory T Cell Immunomonitoring"Iole Macchia, Valentina La Sorsa, Irene Ruspantini, et al.
Nature Medicine|August 21, 2025
GD2-targeting CAR T cells in high-risk neuroblastoma: a phase 1/2 trialFranco Locatelli, Daria Pagliara, Maria A De Ioris, et al.
Journal of Immunology Research|April 24, 2020
Multicentre Harmonisation of a Six-Colour Flow Cytometry Panel for Naïve/Memory T Cell ImmunomonitoringIole Macchia, Valentina La Sorsa, Irene Ruspantini, et al.
Journal of the National Cancer Institute|September 28, 2021
Epigenetic Profiling and Response to CD19 Chimeric Antigen Receptor T-Cell Therapy in B-Cell MalignanciesCarlos A Garcia-Prieto, Lorea Villanueva, Alberto Bueno-Costa, et al.
Cell Death Discovery|August 6, 2024
HDAC3 genetic and pharmacologic inhibition radiosensitizes fusion positive rhabdomyosarcoma by promoting DNA double-strand breaksMatteo Cassandri, Antonella Porrazzo, Silvia Pomella, et al.
Pageof 9

Showing results (71-80 of 89) with videos related to

Sort By:
Pageof 9
Frontiers in Immunology|June 12, 2023
Functional CVIDs phenotype clusters identified by the integration of immune parameters after BNT162b2 boostersEva Piano Mortari, Federica Pulvirenti, Valentina Marcellini, et al.
Neuro-Oncology|December 29, 2021
Dual IGF1R/IR inhibitors in combination with GD2-CAR T-cells display a potent anti-tumor activity in diffuse midline glioma H3K27M-mutantEmmanuel de Billy, Marsha Pellegrino, Domenico Orlando, et al.
Acta Neuropathologica|July 24, 2021
Targeting cancer stem cells in medulloblastoma by inhibiting AMBRA1 dual function in autophagy and STAT3 signallingFrancesca Nazio, Agnese Po, Luana Abballe, et al.
Journal for Immunotherapy of Cancer|May 16, 2022
Time 2EVOLVE: predicting efficacy of engineered T-cells - how far is the bench from the bedside?Sonia Guedan, Maik Luu, Delphine Ammar, et al.
Haematologica|May 9, 2020
CD28.OX40 co-stimulatory combination is associated with long in vivo persistence and high activity of CAR.CD30 T-cellsMarika Guercio, Domenico Orlando, Stefano Di Cecca, et al.
Journal of Immunology Research|August 28, 2020
Corrigendum to "Multicentre Harmonisation of a Six-Colour Flow Cytometry Panel for Naïve/Memory T Cell Immunomonitoring"Iole Macchia, Valentina La Sorsa, Irene Ruspantini, et al.
Nature Medicine|August 21, 2025
GD2-targeting CAR T cells in high-risk neuroblastoma: a phase 1/2 trialFranco Locatelli, Daria Pagliara, Maria A De Ioris, et al.
Journal of Immunology Research|April 24, 2020
Multicentre Harmonisation of a Six-Colour Flow Cytometry Panel for Naïve/Memory T Cell ImmunomonitoringIole Macchia, Valentina La Sorsa, Irene Ruspantini, et al.
Journal of the National Cancer Institute|September 28, 2021
Epigenetic Profiling and Response to CD19 Chimeric Antigen Receptor T-Cell Therapy in B-Cell MalignanciesCarlos A Garcia-Prieto, Lorea Villanueva, Alberto Bueno-Costa, et al.
Cell Death Discovery|August 6, 2024
HDAC3 genetic and pharmacologic inhibition radiosensitizes fusion positive rhabdomyosarcoma by promoting DNA double-strand breaksMatteo Cassandri, Antonella Porrazzo, Silvia Pomella, et al.
Pageof 9